In a new study researcher from Briton has developed a simple and cheap blood test which can mark Alzheimer’s up to ten years prior to the symptoms show is being developed. This test would permit mush earlier prescription for the treatment. The test would also provide more time to sufferers and their families to get ready for the future.
Present diagnosis for Alzheimer’s disease is based on the memory tests and expensive brain scans. Nevertheless many critical evidence of the disease typically drives from the inspection of the patients’ brain after death. But in new study experts from institute of psychiatry at King’s College London have revealed that level of blood protein known as clusterin increase years before the first symptoms of Alzheimer’s emerge.
The increased level of clusterin causes more brain shrink and individual becomes more forgetful. The major goal of in Alzheimer’s research is to develop a test that is inexpensive and easily administered to precisely detect and track the development of the overwhelming disease, said researcher Dr Madhav Thambisetty.
Recognizing clusterin as blood biomarker which might be pertinent to both the pathology and symptoms of the disease might bring them closer to that goal. The test would be as cheap as chip, explained head researcher professor Simon Lovestone. He imagines it being given to adults having family history of the disease and those with diabetes and other conditions that increase their chances of developing Alzheimer’s.
The newest test that would possibly be used in combination with offered diagnostic methods could also be used to help healthcare providers to differentiate normal memory lapses from early stage to dementia. The test kit could also accelerate the development of crucial new medicines.